The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
A multicenter, randomized, controlled trial of totally percutaneous access versus open femoral exposure for endovascular aortic aneurysm repair (the PEVAR trial)
Open accessAbstract
OBJECTIVE: The first multicenter randomized controlled trial was designed and conducted to assess the safety and effectiveness of totally percutaneous endovascular aortic aneurysm repair (PEVAR) with use of a 21F endovascular stent graft system and either an 8 F or 10 F suture-mediated closure system (the PEVAR trial, NCT01070069). A noninferiority trial design was chosen to compare percutaneous access with standard open femoral exposure. METHODS: Between 2010 and 2012, 20 U.S. institutions participated in a prospective, Food and Drug Administration-approved randomized trial to evaluate percutaneous femoral artery access and closure by a "preclose" technique in conjunction with endovascular abdominal aortic aneurysm repair. A total of 151 patients were allocated by a 2:1 design to percutaneous access/closure (n = 101) or open femoral exposure (n = 50 [FE]). PEVAR procedures were performed with either the 8 F Perclose ProGlide (n = 50 [PG]) or the 10 F Prostar XL (n = 51 [PS]) closure devices. All endovascular abdominal aortic aneurysm repair procedures were performed with the Endologix 21 F profile (outer diameter) sheath-based system. Patients were screened by computed tomography with three-dimensional reconstruction and independent physician review for anatomic suitability and adequate femoral artery anatomy for percutaneous access. The primary trial end point (treatment success) was defined as procedural technical success and absence of major adverse events and vascular complications at 30 days. An independent access closure substudy evaluated major access-related complications. Clinical utility and procedural outcomes, ankle-brachial index, blood laboratory analyses, and quality of life were also evaluated with continuing follow-up to 6 months. RESULTS: Baseline characteristics were similar among groups. Procedural technical success was 94% (PG), 88% (PS), and 98% (FE). One-month primary treatment success was 88% (PG), 78% (PS), and 78% (FE), demonstrating noninferiority vs FE for PG (P = .004) but not for PS (P = .102). Failure rates in the access closure substudy analyses demonstrated noninferiority of PG (6%; P = .005), but not of PS (12%; P = .100), vs FE (10%). Compared with FE, PG and PS yielded significantly shorter times to hemostasis and procedure completion and favorable trends in blood loss, groin pain, and overall quality of life. Initial noninferiority test results persist to 6 months, and no aneurysm rupture, conversion to open repair, device migration, or stent graft occlusion occurred. CONCLUSIONS: Among trained operators, PEVAR with an adjunctive preclose technique using the ProGlide closure device is safe and effective, with minimal access-related complications, and it is noninferior to standard open femoral exposure. Training, experience, and careful application of the preclose technique are of paramount importance in ensuring successful, sustainable outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SF-36 health survey: Manual and interpretation guide
Ware, J. (2003) · Medical Entomology and Zoology · Cited by 11,424
Total percutaneous access for endovascular aortic aneurysm repair (“Preclose” technique)
Lee, W. A., Brown, M. P., Nelson, P. R., & Huber, T. S. (2007) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2007.01.050 · Cited by 255
Self-citationSweet, M. P., Fillinger, M. F., Morrison, T. M., & Abel, D. B. (2011) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2011.02.054 · Cited by 195
Lee, W. A., Brown, M. P., Nelson, P. R., Huber, T. S., & Seeger, J. M. (2008) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2007.12.029 · Cited by 176
Self-citationJean‐Baptiste, E., Hassen‐Khodja, R., Haudebourg, P., Bouillanne, P.-J., Declémy, S., & Batt, M. (2008) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2007.10.021 · Cited by 76
Cited by
Chaikof, E. L., Dalman, R. L., Eskandari, M. K., Jackson, B. M., Lee, W. A., Mansour, M. A., Mastracci, T. M., Mell, M., Murad, M. H., Nguyen, L. L., et al. (2018) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2017.10.044 · Cited by 2,751
Isselbacher, E. M., Preventza, O., Hamilton Black, J., Augoustides, J. G., Beck, A. W., Bolen, M. A., Braverman, A. C., Bray, B. E., Brown-Zimmerman, M. M., Chen, E. P., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001106 · Cited by 2,082
2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease
Isselbacher, E. M., Preventza, O., Hamilton Black III, J., Augoustides, J. G., Beck, A. W., Bolen, M. A., Braverman, A. C., Bray, B. E., Brown-Zimmerman, M. M., Chen, E. P., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.08.004 · Cited by 619
EACTS/STS Guidelines for diagnosing and treating acute and chronic syndromes of the aortic organ
Czerny, M., Grabenwöger, M., Berger, T., Aboyans, V., Della Corte, A., Chen, E. P., Desai, N. D., Dumfarth, J., Elefteriades, J. A., Etz, C. D., et al. (2024) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezad426 · Cited by 412
Upchurch, G. R., Escobar, G. A., Azizzadeh, A., Beck, A. W., Conrad, M. F., Matsumura, J. S., Murad, M. H., Perry, R. J., Singh, M. J., Veeraswamy, R. K., et al. (2021) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2020.05.076 · Cited by 379
Metadata
- Authors
- Nelson, P. R., Kracjer, Z., Kansal, N., Rao, V., Bianchi, C., Hashemi, H., Jones, P., & Bacharach, J. M.
- Venue
- Journal of Vascular Surgery
- Publisher
- Elsevier BV
- Published
- 2014-05
- Volume
- 59
- Issue
- 5
- Pages
- 1181-1193
- ISSN
- 0741-5214 (ISSN-L)
- OpenAlex
- W2050359592
- Cited by
- 281
- References
- 5
- FWCI
- 17.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A multicenter, randomized, controlled trial of totally percutaneous access versus open femoral exposure for endovascular aortic aneurysm repair (the PEVAR trial). https://app.cochat.ai/papers/10.1016/j.jvs.2013.10.101
- The paper
- Nelson, P. R., Kracjer, Z., Kansal, N., Rao, V., Bianchi, C., Hashemi, H., Jones, P., & Bacharach, J. M. (2014). A multicenter, randomized, controlled trial of totally percutaneous access versus open femoral exposure for endovascular aortic aneurysm repair (the PEVAR trial). Journal of Vascular Surgery. https://doi.org/10.1016/j.jvs.2013.10.101
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.